Law360, New York (February 11, 2010, 3:53 PM ET) -- A magistrate judge has denied a bid by the Whitehead Institute for Biomedical Research, the Massachusetts Institute of Technology and the University of Massachusetts to strike the Max Planck Institute's demand for a jury in a suit over the licensing of RNA interference patents worth millions.
Magistrate Judge Judith Gail Dein of the U.S. District Court for the District of Massachusetts ruled Wednesday that Max Planck; its licensing arm; and Alnylam Pharmaceuticals Inc., which licenses the patents, are entitled to a jury trial because they have...
Jury To Hear Max Planck RNA Interference Patent Suit
To view the full article, take a free trial now.
